275 related articles for article (PubMed ID: 19060919)
1. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells.
Hong SH; Osborne T; Ren L; Briggs J; Mazcko C; Burkett SS; Khanna C
Vet Comp Oncol; 2011 Sep; 9(3):207-18. PubMed ID: 21848623
[TBL] [Abstract][Full Text] [Related]
3. Ezrin and moesin expression in canine and feline osteosarcoma.
Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
[TBL] [Abstract][Full Text] [Related]
4. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell.
Di Cristofano C; Leopizzi M; Miraglia A; Sardella B; Moretti V; Ferrara A; Petrozza V; Della Rocca C
Mod Pathol; 2010 Jul; 23(7):1012-20. PubMed ID: 20348881
[TBL] [Abstract][Full Text] [Related]
6. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
[TBL] [Abstract][Full Text] [Related]
7. Ezrin, a key component in tumor metastasis.
Hunter KW
Trends Mol Med; 2004 May; 10(5):201-4. PubMed ID: 15121044
[TBL] [Abstract][Full Text] [Related]
8. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
9. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
Khanna C; Wan X; Bose S; Cassaday R; Olomu O; Mendoza A; Yeung C; Gorlick R; Hewitt SM; Helman LJ
Nat Med; 2004 Feb; 10(2):182-6. PubMed ID: 14704791
[TBL] [Abstract][Full Text] [Related]
10. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box.
Çelik H; Hong SH; Colón-López DD; Han J; Kont YS; Minas TZ; Swift M; Paige M; Glasgow E; Toretsky JA; Bosch J; Üren A
Mol Cancer Ther; 2015 Nov; 14(11):2497-507. PubMed ID: 26358752
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma.
Ren L; Hong SH; Chen QR; Briggs J; Cassavaugh J; Srinivasan S; Lizardo MM; Mendoza A; Xia AY; Avadhani N; Khan J; Khanna C
Cancer Res; 2012 Feb; 72(4):1001-12. PubMed ID: 22147261
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma metastasis: prospective role of ezrin.
Zhang Y; Zhang L; Zhang G; Li S; Duan J; Cheng J; Ding G; Zhou C; Zhang J; Luo P; Cai D; Kuang L; Zhou Y; Tong L; Yu X; Zhang L; Xu L; Yu L; Shi X; Ke A
Tumour Biol; 2014 Jun; 35(6):5055-9. PubMed ID: 24609902
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
[TBL] [Abstract][Full Text] [Related]
16. Actin microdomains on endothelial cells: association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing.
Jensen PV; Larsson LI
Histochem Cell Biol; 2004 May; 121(5):361-9. PubMed ID: 15103468
[TBL] [Abstract][Full Text] [Related]
17. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity.
Zucchini C; Manara MC; Pinca RS; De Sanctis P; Guerzoni C; Sciandra M; Lollini PL; Cenacchi G; Picci P; Valvassori L; Scotlandi K
Oncogene; 2014 Apr; 33(15):1912-21. PubMed ID: 23644663
[TBL] [Abstract][Full Text] [Related]
18. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.
Bulut G; Hong SH; Chen K; Beauchamp EM; Rahim S; Kosturko GW; Glasgow E; Dakshanamurthy S; Lee HS; Daar I; Toretsky JA; Khanna C; Uren A
Oncogene; 2012 Jan; 31(3):269-81. PubMed ID: 21706056
[TBL] [Abstract][Full Text] [Related]
20. siRNAs target sites selection of ezrin and the influence of RNA interference on ezrin expression and biological characters of osteosarcoma cells.
Shang X; Wang Y; Zhao Q; Wu K; Li X; Ji X; He R; Zhang W
Mol Cell Biochem; 2012 May; 364(1-2):363-71. PubMed ID: 22286748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
